Cyclic GMP signaling in rat urinary bladder, prostate, and epididymis: Tissue-specific changes with aging and in response to Leydig cell depletion

Reproduction

Volumn 142, Issue 2, 2011, Pages 333-343

  Müller, Dieter ^a   Mukhopadhyay, Amal K ^b   Davidoff, Michail S ^c   Middendorff, Ralf ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ELGA Biotech   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; PHOSPHODIESTERASE V; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CELL MEMBRANE; EPIDIDYMIS; LEYDIG CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

AGING; ANDROGENS; ANIMALS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; CYTOSOL; DOWN-REGULATION; EPIDIDYMIS; LEYDIG CELLS; MALE; MESYLATES; ORGAN SPECIFICITY; PROSTATE; RATS; RATS, WISTAR; SECOND MESSENGER SYSTEMS; SPERMATOGENESIS; UP-REGULATION; URINARY BLADDER;

RATTUS; RATTUS NORVEGICUS;

EID: 79960650281     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-10-0517     Document Type: Article

References (49)

1. Alderton WK, Cooper CE & Knowles RG 2001 Nitric oxide synthases: structure, function and inhibition. Biochemical Journal 357 593-615. (doi:10.1042/0264-6021:3570593)
2. Andersson KE & Arner A 2004 Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiological Reviews 84 935-986. (doi:10.1152/physrev.00038.2003)
3. Andersson KE, Uckert S, Stief C & Hedlund C 2007 Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourology and Urodynamics 26 928-933. (doi:10.1002/nau.20485)
4. Barber RD, Harmer DW, Coleman RA & Clark BJ 2005 GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 21 389-395. (doi:10.1152/physiolgenomics.00025.2005)
5. Bubikat A, De Windt LJ, Zetsche B, Fabritz L, Sickler H, Eckardt D, Gödecke A, Baba HA & Kuhn M 2005 Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitricoxide synthase-deficient mice. Journal of Biological Chemistry 280 21594-21599. (doi:10.1074/jbc.M501103200)
6. Caremel R, Oger-Roussel S, Behr-Roussel D, Grise P & Giuliano FA 2010 Nitric oxide/cyclic guanosine monophosphate signaling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. European Urology 58 616-625. (doi:10.1016/j.eururo.2010.07.026)
7. Corbin JD, Beasley A, Blount MA & Francis SH 2005 High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors. Biochemical and Biophysical Research Communications 334 930-938. (doi:10.1016/j.bbrc.2005.06.183)
8. Davidoff MS,MiddendorffM, EnikolopovG, RiethmacherD,Holstein AF & Müller D 2004 Progenitor cells of the testosterone-producing Leydig cells revealed. Journal of Cell Biology 167 935-944. (doi:10.1083/jcb.200409107)
9. Davidoff MS, Middendorff R, Müller D & Holstein AF 2009 The neuroendocrine Leydig cells and their stem cell progenitors, the pericytes. Advances in Anatomy, Embryology, and Cell Biology 205 1-107.
10. Dimitriadis F, Tsounapi P, Saito M, Watanabe T, Sylakos A, Tsabalas S, Miyagawa I & Sofikitis N 2009 Is there a role for PDE5 inhibitors in the management of male infertility due to defects in testicular or epididymal function? Current Pharmaceutical Design 15 3506-3520. (doi:10.2174/ 138161209789207015)
11. Domek-£opacińska KU & Strosznajder JB 2010 Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease. Molecular Neurobiology 41 129-137. (doi:10.1007/s12035-010-8104-x)
12. Eskenazi B, Wyrobek AJ, Sloter E, Kidd SA, Moore L, Young S & Moore D 2003 The association of age and semen quality in healthy men. Human Reproduction 18 447-454. (doi:10.1093/humrep/deg107)
13. Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P et al. 2010 Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. Journal of Sexual Medicine 7 59-69. (doi:10.1111/j.1743- 6109.2009.01511.x)
14. Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, Gacci M, Vignozzi L, Vannelli GB, Carini M et al. 2007 Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 148 1019-1029. (doi:10.1210/en.2006-1079)
15. Ghofrani HA, Osterloh IH & Grimminger F 2006 Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Reviews. Drug Discovery 5 689-702. (doi:10.1038/nrd2030)
16. Goldstein AS, Huang J, Guo C, Garraway IP & Witte ON 2010 Identification of a cell of origin for human prostate cancer. Science 329 568-571. (doi:10.1126/science.1189992)
17. Gradini R, Realacci M, Ginepri A, Naso G, Santangelo C, Cela O, Sale P, Berardi A, Petrangeli E, Gallucci M et al. 1999 Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. Journal of Pathology 189 224-229. (doi:10.1002/(SICI)1096-9896(199910) 189:2〈224::AID-PATH422〉3.0.CO;2-K)
18. Halvey EJ, Vernon J, Roy B & Garthwaite J 2009 Mechanisms of activity-dependent plasticity in cellular nitric oxide-cGMP signaling. Journal of Biological Chemistry 284 25630-25641. (doi:10.1074/jbc.M109.030338)
19. Hofmann F, Feil R, Kleppisch T & Schlossmann J 2006 Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiological Reviews 86 1-23. (doi:10.1152/physrev.00015.2005)
20. Kedia GT, Uckert S, Jonas U, Kuczyk MA & Burchardt M 2008 The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms. World Journal of Urology 26 603-609. (doi:10.1007/s00345-008-0303-y)
21. Kuhn M 2009 Function and dysfunction of mammalian membrane guanylyl cyclase receptors: lessons from genetic mouse models and implications for human diseases. Handbook of Experimental Pharmacology 191 47-69. (doi:10.1007/978-3- 540-68964-5-4)
22. Lagou M, Drake MJ, Markerink-van Ittersum M, De Vente J & Gillespie JI 2006 Interstitial cells and phasic activity in the isolated mouse bladder. British Journal of Urology International 98 643-650. (doi:10.1111/j.1464-410X. 2006.06255.x)
23. Lang SH, Frame FM & Collins AT 2009 Prostate cancer stem cells. Journal of Pathology 217 299-306. (doi:10.1002/path.2478)
24. Love HD, Booton SE, Boone BE, Breyer JP, Koyama T, Revelo MP, Shappell SB, Smith JR & Hayward SW 2009 Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer. PLoS ONE 4 e8384. (doi:10.1371/journal.pone.0008384)
25. Lukowski R, Rybalkin SD, Loga F, Leiss V, Beavo JA & Hofmann F 2010 Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes. PNAS 107 5646-5651. (doi:10.1073/pnas.1001360107)
26. Mewe M, Bauer CK, Müller D & Middendorff R 2006 Regulation of spontaneous contractile activity in the bovine epididymal duct by cyclic guanosine 50-monophosphate-dependent pathways. Endocrinology 147 2051-2062. (doi:10.1210/en.2005-1324)
27. Midzak AS, Chen H, Papadopoulos V & Zirkin BR 2009 Leydig cell aging and the mechanisms of reduced testosterone synthesis. Molecular and Cellular Endocrinology 299 23-31. (doi:10.1016/j.mce.2008.07.016)
28. Molenaar R, de Rooij DG, Rommerts FF, Reuvers PJ & van der Molen HJ 1985 Specific destruction of Leydig cells in mature rats after in vivo administration of ethane dimethyl sulfonate. Biology of Reproduction 33 1213-1222. (doi:10.1095/biolreprod33.5.1213)
29. Morelli A, Filippi S, Mancina R, LuconiM, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A et al. 2004 Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 145 2253-2263. (doi:10.1210/en.2003-1699)
30. Müller D, Middendorff R, Olcese J & Mukhopadhyay AK 2002 Central nervous system-specific glycosylation of the type A natriuretic peptide receptor. Endocrinology 143 23-29. (doi:10.1210/en.143.1.23)
31. Müller D, Mukhopadhyay AK, Speth RC, Guidone G, Potthast R, Potter LR & Middendorff R 2004 Spatiotemporal regulation of the two atrial natriuretic peptide receptors in testis. Endocrinology 145 1392-1401. (doi:10.1210/en.2003-0706)
32. Müller D, Greenland KJ, Speth RC & Middendorff R 2010a Neuronal differentiation of NG108-15 cells has impact on nitric oxide- and membrane (natriuretic peptide receptor-A) cyclic GMP-generating proteins. Molecular and Cellular Endocrinology 320 118-127. (doi:10. 1016/j.mce.2010.01.022)
33. Müller D, Hildebrand M, Lübberstedt J, Kuhn M & Middendorff R 2010b The membrane receptors guanylyl cyclase-A (GC-A) and GC-B undergo distinctive changes in posttranslational modification during brain development. Journal of Neurochemistry 115 1024-1034. (doi:10.1111/j.1471-4159.2010.06985.x)
34. Nielsen SJ, Gøtze JP, Jensen HL & Rehfeld JF 2008 ProCNP and CNP are expressed primarily in male genital organs. Regulatory Peptides 146 204-212. (doi:10.1016/j.regpep.2007.09.022)
35. Paust HJ, Wessels J, Ivell R & Mukhopadhyay AK 2002 The expression of the RLF/INSL3 gene is reduced in Leydig cells of the aging rat testis. Experimental Gerontology 37 1461-1467. (doi:10.1016/S0531-5565(02)00098-0)
36. Persson K, Pandita RK, Aszò di A, Ahmad M, Pfeifer A, Fässler R & Andersson K-E 2000 Functional characteristics of urinary tract smooth muscles in mice lacking cGMP protein kinase type I. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 279 R1112-R1120.
37. SabbatiniME 2009 Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Regulatory Peptides 154 5-15. (doi:10.1016/j.regpep.2009.02.009)
38. Sampson N, Untergasser G, Plas E & Berger P 2007 The ageing male reproductive tract. Journal of Pathology 211 206-218. (doi:10.1002/path.2077)
39. Sandner P, Neuser D & Bischoff E 2009 Erectile dysfunction and lower urinary tract. Handbook of Experimental Pharmacology 191 507-531.
40. Shum WW, Da Silva N, McKee M, Smith PJ, Brown D & Breton S 2008 Transepithelial projections from basal cells are luminal sensors in pseudostratified epithelia. Cell 135 1108-1117. (doi:10.1016/j.cell.2008.10.020)
41. Stice JP, Eiserich JP & Knowlton AA 2009 Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology 150 212-219. (doi:10.1210/en.2008-0640)
42. Syntin P & Robaire B 2001 Sperm structural and motility changes during aging in the Brown Norway rat. Journal of Andrology 22 235-244. (Pubitemid 32174184)
43. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y & Kass DA 2005a Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nature Medicine 11 214-222. (doi:10.1038/nm1175)
44. Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, Isoda T, Aufiero K, Zaccolo M et al. 2005b cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism. Circulation Research 96 100-109. (doi:10.1161/01.RES.0000152262. 22968.72)
45. Takimoto E, Koitabashi N, Hsu S, Ketner EA, Zhang M, Nagayama T, Bedja D, Gabrielson KL, Blanton R, Siderovski DP et al. 2009 Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. Journal of Clinical Investigation 119 408-420. (doi:10.1172/JCI35620)
46. de Vente J, Markerink-van Ittersum M & Gillespie JI 2007 Natriuretic peptide responsive, cyclic guanosine monophosphate producing structures in the guinea pig bladder. Journal of Urology 177 1191-1194. (doi:10.1016/j.juro.2006. 10.039)
47. Wang C 2010 Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia. Current Opinion in Urology 20 49-54. (doi:10.1097/MOU. 0b013e328333ac68)
48. Zenzmaier C, Sampson N, Pernkopf D, Plas E, Untergasser G & Berger P 2010 Attenuated proliferation and trans-differentiation of prostatic stromal cells indicate suitability of phosphodiesterase type 5 inhibitors for prevention and treatment of benign prostatic hyperplasia. Endocrinology 151 3975-3984. (doi:10.1210/en.2009-1411)
49. Zhao W, Aboushwareb T, Turner C, Mathis C, Bennett C, Sonntag WE, Andersson K-E & Christ G 2010 Impaired bladder function in aging male rats. Journal of Urology 184 378-385. (doi:10.1016/j.juro.2010.03.004)